MSHNX
Price
$15.26
Change
+$0.11 (+0.73%)
Updated
Sep 4 closing price
Net Assets
5.62M
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

MSHNX vs RGEBX

Header iconMSHNX vs RGEBX Comparison
Open Charts MSHNX vs RGEBXBanner chart's image
Morgan Stanley Inst Permanence A
Price$15.26
Change+$0.11 (+0.73%)
VolumeN/A
Net Assets5.62M
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
MSHNX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MSHNX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSHNX is a Hold and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. MSHNX (5.62M). MSHNX pays higher dividends than RGEBX: MSHNX (1.94) vs RGEBX (0.00). MSHNX was incepted earlier than RGEBX: MSHNX (5 years) vs RGEBX (11 years). MSHNX (7.95) is less costly to investors than RGEBX (1.09). MSHNX is a more actively managed with annual turnover of: 74.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MSHNX: RGEBX (250) vs MSHNX (1000). RGEBX annual gain was more profitable for investors over the last year : 17.59 vs. MSHNX (14.85). RGEBX return over 5 years is better than : 38.71 vs. MSHNX (13.56).
MSHNXRGEBXMSHNX / RGEBX
Total Expense Ratio1.201.09110%
Annual Report Gross Expense Ratio7.951.09729%
Fund Existence5 years11 years-
Gain YTD21.20715.398138%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets5.62M332B0%
Annual Yield % from dividends1.940.00-
Returns for 1 year14.8517.5984%
Returns for 3 years40.2657.6170%
Returns for 5 years13.5638.7135%
Returns for 10 yearsN/A91.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In